Immunotherapy of cancer with polymeric prodrugs: from dream to reality
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F09%3A00340767" target="_blank" >RIV/61388971:_____/09:00340767 - isvavai.cz</a>
Alternative codes found
RIV/61389013:_____/09:00340767
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Immunotherapy of cancer with polymeric prodrugs: from dream to reality
Original language description
Appropriate treatment with HPMA bound doxorubicin can, in contrast to its parental drug alone, eradicate the tumor and thus activate protective anti-tumor immunity
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
EC - Immunology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů